Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
NovImmune
222
NovImmune
Technology
Biotechnology
NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.
Suggest edits
Founded
1998
Raised
$137.2M
Follow us
Also headquartered in Geneva
Seedstars
Seedstars World
ProtonMail
World Economic Forum
CERN
Index Ventures
WHO
Temenos
Silent Circle
STMicroelectronics
Companies in the same industry
Triage Consulting Group
Syros Pharmaceuticals
Prenetics
Celgene Corporation
Interface Biologics
Entopsis
RetroVirox
Cure Forward
Procept BioRobotics
InfoBionic
Alexa global traffic share
